About this trial

The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are:

* whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.

Eligibility criteria

Qualifiers

All patients undergoing surgery for reverse total shoulder arthroplasty

Patients willing and able to provide informed consent

Disqualifiers

Revision arthroplasty

Reverse shoulder arthroplasty for proximal humerus fractures

Adults unable to consent

Individuals who are not yet adults (infants, children, teenagers)

Trial design

Treatments tested in this trial

  • Pectoralis Minor Release
  • RSA

Treatment groups

90 Participants
are divided into 2 treatment groups

Locations

2
Emory Clinic30322, AtlantaGeorgia, United States
Emory Healthcare Orthopaedics and Spine Center30329, AtlantaGeorgia, United States

Sponsors and collaborators

Emory University

Lead sponsor